Charles Howard Adler, MD, PhD

  • 21628 Citations
  • 68 Scopus h-Index
1977 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Charles Howard Adler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Synucleins Medicine & Life Sciences
Lewy Bodies Medicine & Life Sciences
Lewy Body Disease Medicine & Life Sciences
Restless Legs Syndrome Medicine & Life Sciences
Essential Tremor Medicine & Life Sciences
Dementia Medicine & Life Sciences
Pathology Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2019

  • 21628 Citations
  • 68 Scopus h-Index
  • 300 Article
  • 4 Review article
  • 3 Chapter
  • 3 Comment/debate
1 Citation (Scopus)

Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson's Disease

Driver-Dunckley, E. M., Zhang, N., Adler, C. H., Serrano, G. E., Sue, L. I., Shill, H. A., Mehta, S., Belden, C. M., Zamrini, E. Y., Davis, K. & Beach, T. G., Jan 1 2019, In : Journal of Parkinson's disease. 9, 3, p. 543-552 10 p.

Research output: Contribution to journalArticle

Parkinson Disease
Cardiovascular Diseases
Submandibular Gland

Erratum: Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: An expert consensus (Journal of Physical Chemistry (2018) 23:6 (402-413) DOI: 10.1017/S1092852918001359)

Black, K. J., Nasrallah, H., Isaacson, S., Stacy, M., Pahwa, R., Adler, C. H., Alva, G., Cooney, J. W., Kremens, D., Menza, M. A., Meyer, J. M., Patkar, A. A., Simuni, T., Morrissette, D. A. & Stahl, S. M., Jan 1 2019, In : CNS Spectrums.

Research output: Contribution to journalComment/debate

Open Access
Physical Chemistry
Psychotic Disorders
Antipsychotic Agents
Parkinson Disease

Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease

El-Nazer, R., Adler, C. H., Beach, T. G., Belden, C. M., Artz, J., Shill, H. A., Driver-Dunckley, E. M., Mehta, S., Sabbagh, M. N., Serrano, G. E., Sue, L. I., Zamrini, E. & Benge, J. F., Jan 1 2019, In : Parkinsonism and Related Disorders.

Research output: Contribution to journalArticle

Lewy Bodies
Neurofibrillary Tangles
Parkinson Disease
Temporal Lobe

Risk of Parkinson's disease dementia related to level I MDS PD-MCI

on behalf of the MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”, Jan 1 2019, (Accepted/In press) In : Movement Disorders.

Research output: Contribution to journalArticle

Parkinson Disease
Movement Disorders
Survival Analysis
3 Citations (Scopus)

Tau immunoreactivity in peripheral tissues of human aging and select tauopathies

Dugger, B. N., Hoffman, B. R., Scroggins, A., Serrano, G. E., Adler, C. H., Shill, H. A., Belden, C. M., Sabbagh, M. N., Caviness, J. N., Driver-Dunckley, E. M. & Beach, T. G., Mar 23 2019, In : Neuroscience Letters. 696, p. 132-139 8 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Submandibular Gland
Sigmoid Colon